Evidence-graded · Source-cited Peer-reviewer panel · 6 clinicians
PeptideVox
Legal

Privacy Policy

Last updated June 30, 2026

This Privacy Policy explains how PeptideVox (“PeptideVox,” “we,” “us,” or “our”) collects, uses, discloses, and retains information in connection with peptidevox.com and the The Evidence Brief newsletter (collectively, the “Services”). By using the Services, you agree to the practices described here.

Information we collect

We collect the following categories of information:

How we use information

We use information to operate and improve the Services, including to:

How we share information

We do not sell your personal information for money. We may share information with service providers who process it on our behalf — including email delivery, analytics, hosting, content delivery, and security vendors — and with others as needed to operate the Services. We may also disclose information to comply with law or legal process; to protect our rights, users, and the public; and in connection with a merger, financing, acquisition, or other business transaction.

Cookies and analytics

We use cookies and similar technologies to run the Services, remember preferences, and measure traffic and engagement, including through third-party analytics. You can control cookies through your browser settings; disabling them may affect how the Services function.

Your choices and rights

You can unsubscribe from the newsletter at any time using the link in any email. Depending on where you live, you may have rights to access, correct, delete, or limit the use of your personal information. To make a request, email editor@peptidevox.com. We will respond as required by applicable law and may need to verify your identity before acting.

Data retention and security

We retain information for as long as needed to provide the Services, pursue the purposes above, and meet legal requirements, after which we delete or de-identify it. We use reasonable administrative, technical, and organizational safeguards, but no method of transmission or storage is completely secure, and we cannot guarantee absolute security.

International users and children

The Services are operated from the United States and intended for a US audience; by using them you consent to processing in the United States. The Services are not directed to children under 13 (or the minimum age in your jurisdiction), and we do not knowingly collect their information.

Changes to this policy

We may update this Privacy Policy from time to time. Changes are effective when posted, and your continued use of the Services after an update constitutes acceptance. Questions? Contact editor@peptidevox.com.

Medical Disclaimer · Read in full

PeptideVox is an evidence reference, not medical advice. Nothing here authorizes you to acquire, possess, or self-administer any compound.

01 · Not FDA-approved

The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.

02 · Research chemicals

Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.

03 · WADA-prohibited

Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.

04 · Consult a clinician

Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.

This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.